Exelixis and Arcus Announce Trial Collaboration to Evaluate Zanzalintinib
Exelixis Announces Initiation of the STELLAR-305 Phase 2/3 Pivotal Trial
Exelixis Announces Results from Expansion Cohort of Phase 1b STELLAR-001 Trial